Dr
Peter Lockey
Peter is Director of Biochemistry and Screening at Argenta Discovery, and was one of the original founders of the company from Aventis, where he lead teams in both the High Throughput Screening and Assay Development groups.
He holds degrees in Biochemistry, and Medicinal Chemistry, and his PhD research focused on drug targeting in cancer chemotherapy. Peter has over 20 years of experience in the Pharmaceutical industry.
Argenta Discovery Limited is a company incorporated and registered in England with registered number 3671653 whose registered office and principal place of business is at 8/9 Spire Green Centre, Flex Meadow, Harlow, CM19 5TR, United Kingdom and whose VAT registration number is GB 848 2268 02.